News

Two new DeepChek® applications dedicated to viral hepatitis B (HBV) and hepatitis C (HCV) are now available in BaseSpace, the Illumina’s dedicated applications store and cloud-based informatics community dedicated to advancing genomic analysis. See the press release about BaseSpace and Illumina.

ABL will be participating to the next Illumina BaseSpace Worldwide Developers Conference (WWDC) in San Francisco on the 8th and 9th of December 2014. View more

ABL S.A, The University of Hong Kong and The Hong Kong Polytechnic University are launching their collaborative tuberculosis (TB) project to develop a deep-sequencing assay and its tailored bio-informatics pipeline. View more

ABL is pleased to announce a new collaboration with the New Zealand Liver Transplant Unit and LabPlus at Auckland City Hospital. This will evaluate the susceptibility to develop Hepatocellular Carcinoma (HCC) during 30 years follow-up, based on key baseline genomic variations of HBV in a large cohor…

ABL and Mayo Medical Laboratories will develop novel innovative LDT and related IT in the field of virology. More details available here.

Advanced Biological Laboratories (ABL) and Roche Diagnostics International renew and extend their collaboration agreement to promote their Next-Generation Sequencing, Genotyping and Drug Resistance Products. See the full press release.

First virology application on BaseSpace to deal with HIV next generation sequencing coming from Illumina’s platforms. See the press release about BaseSpace and Illumina.

ABL entered into an exclusive worldwide licensing agreement with CRP-Santé for its COMET software designed for high performance DNA sequencing analysis and classification.See full Press Release.